| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 86 | 2.323 | 0 | 0 | 0 | - | 56.429 |
| Total Income - EUR | - | - | - | 176 | -4.319 | 0 | 342 | 0 | - | 56.429 |
| Total Expenses - EUR | - | - | - | 2.661 | 8.762 | 1.398 | 2.054 | 687 | - | 44.356 |
| Gross Profit/Loss - EUR | - | - | - | -2.485 | -13.082 | -1.398 | -1.712 | -687 | - | 12.073 |
| Net Profit/Loss - EUR | - | - | - | -2.490 | -13.158 | -1.398 | -1.723 | -687 | - | 9.645 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 |
Check the financial reports for the company - Revive 5Am Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.005 | 879 | 756 | 654 | - | 0 |
| Current Assets | - | - | - | 8.580 | 16.019 | 15.716 | 20.618 | 12.552 | - | 67.266 |
| Inventories | - | - | - | 8.485 | 7.530 | 7.387 | 12.474 | 12.513 | - | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 59.995 |
| Cash | - | - | - | 95 | 8.489 | 8.328 | 8.144 | 40 | - | 7.271 |
| Shareholders Funds | - | - | - | -2.447 | -15.558 | -16.670 | -18.023 | -21.388 | - | 9.685 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | - | - | - | 11.027 | 34.399 | 34.453 | 39.977 | 34.594 | - | 57.581 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Revive 5Am Labs S.r.l.